Last reviewed · How we verify
Tissue sealant
At a glance
| Generic name | Tissue sealant |
|---|---|
| Also known as | ReSure sealant |
| Sponsor | Stanford University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Trial of Intraoperative Fibrin Sealant on Postoperative Recovery After Total Knee Replacement (PHASE4)
- Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection
- Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU) (PHASE2)
- High-Purity Type I Collagen Augmentation in Meniscal Repair (NA)
- The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study (PHASE3)
- Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers (PHASE1)
- Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate (PHASE2)
- NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |